Taiwan’s Amaran Biotech Takes Top Spot at 2025 Asia-Pacific Biopharma Awards
Amaran Biotech is honored with the IMAPAC “Asia-Pacific Biopharma Excellence
Awards 2025,” receiving the “Bioprocessing Excellence in Taiwan” award. From left: Award
presenter Professor Alois Jungbauer of BOKU University; Ryan Lo, Vice President of Corporate
Strategy at Amaran Biotech; and Dr. Chih-Liang Chang, Advisor of Technical Services at Amaran Biotech. Image: Amaran Biotech.
Taiwan’s next-generation Contract Development and Manufacturing Organization (CDMO), Amaran Biotech, has been recognized for its innovation and leadership in bioprocessing. The company took home the “Bioprocessing Excellence in Taiwan” award at the 2025 Asia-Pacific Biopharma Excellence Awards (ABEA), held in Singapore on March 12. Hosted by leading consulting firm IMAPAC, the annual event celebrates top … Taiwan’s Amaran Biotech Takes Top Spot at 2025 Asia-Pacific Biopharma Awards Read More » To access this post, you must purchase Individual Subscriber Yearly or Enterprise Subscriber.
GO Prime with only $1.49 now
LATEST
Alliance for Clinical Trials in Oncology Highlights Research Initiatives on World Breast Cancer Research Day
2026-08-18
European Patent Office Grants Godavari Biorefineries Patent for Anti-Cancer Drug Formulation
2026-08-18
EVENT
2026-10-20
AusBiotech 2026 (20-23 Oct, Queensland) (Australia biotech & investment)
Queensland, Australia




